Background
==========

As part of a broader methodological programme of work around clinical trial monitoring, we plan to develop a comprehensive central monitoring strategy that is useful to staff developing clinical trial quality management and monitoring plans. In order to facilitate trial operation\'s staff planning a monitoring strategy where procedural and protocol compliance issues can be identified without the need to perform costly and intensive routine on-site data monitoring, we engaged in the current work that explores practical methods to achieve the aims of trial monitoring and trial conduct oversight.

Methods
=======

The current work comprises of 3 components: a literature review; informal interviews and surveys of current practice by trial teams at a large UK Clinical Research Collaboration (UKCRC) registered Clinical Trials Unit engaging in phase II and III clinical trials in cancer and HIV research; and strategy development.

Results
=======

At the time of writing this work is still being conducted. We aim to develop our strategy from the information available from all sources with suggestions for activities centred around: preventing, identifying, monitoring and addressing patient safety and participant rights issues; ensuring, through appropriate trial design and management, the generation of unbiased, accurate and timely data; enhancing trial management processes (including identifying poor performing sites and sites requiring additional support), enhancing protocol compliance, enhancing procedural compliance; and identifying fraudulent activities (fabrication or falsification of data).
